Portfolio News

Clarendo portfolio company Cirdan the medical informatics and imaging technology company has today announced that it has acquired the Belfast-based Philips Digital and Computational Pathology business (formerly known as PathXL). Headquartered in Northern Ireland with offices in Canada and Australia, Cirdan specialises in developing technology that supports and speeds up diagnosis, primarily used by those […]

Clarendon portfolio company Re-Vana Therapeutics the Queen’s University spin-out has secured $3.25 million (€2.9 million) in funding. Among the backers are three specialised US ophthalmic venture capital funds: ExSight, Visionary and InFocus. Re-Vana is a drug delivery company focused on the treatment of chronic eye diseases such as age-related macular degeneration and Glaucoma. The seed